minichart

Trading Opportunities: Xiaomi Corporation and Great Wall Motor Poised for Growth

minichart

September 12, 2024

Key Investment Recommendations: Xiaomi Corporation (1810 HK) & Great Wall Motor Company (2333 HK) As of September 12, 2024, UOB Kay Hian has highlighted Xiaomi Corporation and Great Wall Motor Company as strong trading...

Continue Reading 0

Market Updates

Investment Opportunities in Dyna-Mac, Food Empire, Q&M Dental, and Rex International: Strategic Moves and Market Outlook

minichart

September 12, 2024

Investment Recommendations Dyna-Mac Holdings: BUY (Potential upside with a possible offer increase) Food Empire: HOLD (Solid growth strategy but long-term horizons) Q&M Dental: HOLD (Strategic acquisition with moderate growth prospects) Rex International: HOLD (Short-term...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Investment Opportunities in Singapore Post, and Hongkong Land Holdings: An In-Depth Analysis

minichart

September 12, 2024

Company Highlights Singapore Post (SPOST SP): Currently positioned as a trading buy, Singapore Post’s technical indicators suggest a bullish trend with a potential price target of S$0.495. Hongkong Land Holdings (HKL SP): Hongkong Land...

Continue Reading 0

Hong Kong stocksMarket Updates

Investment Opportunity: China Petroleum & Chemical Corp (Sinopec) – Buy Now Before the Rebound

minichart

September 12, 2024

Company Highlights: China Petroleum & Chemical Corp (Sinopec) is China’s second-largest integrated oil and gas operator and the largest refining player. With strong operations across both upstream and downstream segments, Sinopec remains well-positioned in...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Singapore Exchange (SGX): Trading Volume Growth Spurs Price Rally

minichart

September 12, 2024

Company HighlightsThe focus of this investment report is on Singapore Exchange (SGX). The company is experiencing heightened trading volumes, with a positive outlook on its stock performance driven by various financial factors. Investment RecommendationThe...

Continue Reading 0

Market UpdatesSingapore SGX stocks

“Investment Opportunities: Dyna-Mac and InnoTek Lead the Charge in Singapore’s Stock Market”

minichart

September 12, 2024

Investment Report: This report covers Dyna-Mac Holdings and InnoTek Limited, with a focus on their financial performance, potential catalysts, and investment recommendations. It also includes insights into other top companies such as Jardine Matheson,...

Continue Reading 0

Market UpdatesSingapore SGX stocks

Hyphens Pharma International – A Healthy Pipeline Driving Revenue Growth and Profitability

minichart

September 12, 2024

Company Highlights: Hyphens Pharma International (HYP) has shown a strong performance in the first half of 2024, achieving record revenue of S$99.6 million, a significant 33.4% year-over-year (YoY) increase. The company’s growth was driven...

Continue Reading 0

Hong Kong stocksMarket UpdatesSingapore SGX stocks

Sinarmas Land Ltd and BeiGene Ltd Poised for Growth Amid Bullish Signals

minichart

September 12, 2024

Investment Recommendation: Sinarmas Land Ltd (SIN) and BeiGene Ltd (HKG: 6160) are both recommended buys, based on technical analysis indicating potential upward price movement. Investors are advised to take long positions on both stocks....

Continue Reading 0

Bursa KLSE stocksMarket Updates

Uchi Technologies, AppAsia, and Power Root: Top Investment Picks to Watch

minichart

September 12, 2024

Company Highlights: Uchi Technologies (7100) AppAsia (0119) Power Root (PWRT) Investment Recommendation: For Uchi Technologies and AppAsia, a Technical Buy is recommended, while Power Root is downgraded to Hold due to earnings struggles. Investment...

Continue Reading 0

Hong Kong stocksMarket Updates

Innovent Biologics: Pharma Giant in the Making with Strong Growth Prospects

minichart

September 12, 2024

Company Highlights: Innovent Biologics is evolving from a biotech company to a major pharmaceutical player in China, driven by its diverse drug pipeline. Key drugs such as Sintilimab, the company’s leading anti-PD-1 antibody, and...

Continue Reading 0

Author: minichart